Patents by Inventor Pierre Bize

Pierre Bize has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Liquid nicotine formulation comprising partially water-soluble solvent
    Patent number: 11992038
    Abstract: A liquid nicotine formulation for an aerosol-generating system is provided, the liquid nicotine formulation including: water; and one or more partially water-soluble, water-immiscible solvents having a water solubility at 20° C. of between about 20 mg/ml and about 100 mg/ml, the liquid nicotine formulation having a water content of greater than or equal to about 5 percent by weight and a partially water-soluble, water-immiscible solvent content of between about 2 percent by weight and about 30 percent by weight. A cartridge for an aerosol-generating system, and an aerosol-generating system, are also provided.
    Type: Grant
    Filed: December 31, 2019
    Date of Patent: May 28, 2024
    Assignee: Philip Morris Products S.A.
    Inventors: Jean-Pierre Schaller, Aline Vuarnoz-Bize
  • Chemoembolization composition comprising anti-angiogenic agents
    Patent number: 10537643
    Abstract: The invention relates to chemoembolization compositions for anti-angiogenic agent delivery. The invention further relates to a method of preparing chemoembolization compositions and to the use of chemoembolization compositions in the method for treating solid tumour cancers.
    Type: Grant
    Filed: June 29, 2017
    Date of Patent: January 21, 2020
    Assignee: CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS
    Inventors: Alban Denys, Pierre Bize, Olivier Jordan, Eric Doelker, Nathalie Boulens
  • Chemoembolization Composition Comprising Anti-Angiogenic Agents
    Publication number: 20170296669
    Abstract: The invention relates to chemoembolization compositions for anti-angiogenic agent delivery. The invention further relates to a method of preparing chemoembolization compositions and to the use of chemoembolization compositions in the method for treating solid tumour cancers.
    Type: Application
    Filed: June 29, 2017
    Publication date: October 19, 2017
    Inventors: Alban DENYS, Pierre BIZE, Olivier JORDAN, Eric DOELKER, Nathalie BOULENS
  • Chemoembolization composition comprising anti-angiogenic agents
    Patent number: 9724421
    Abstract: The invention relates to chemoembolization composition for anti-angiogenic agent delivery. The invention further relates to a method of preparing chemoembolization composition and to the use of chemoembolization composition in the method for treating solid tumor cancers.
    Type: Grant
    Filed: November 29, 2011
    Date of Patent: August 8, 2017
    Assignee: CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS
    Inventors: Alban Denys, Pierre Bize, Olivier Jordan, Eric Doelker, Nathalie Boulens
  • CHEMOEMBOLIZATION COMPOSITION COMPRISING ANTI-ANGIOGENIC AGENTS
    Publication number: 20130324548
    Abstract: The invention relates to chemoembolization composition for anti-angiogenic agent delivery. The invention further relates to a method of preparing chemoembolization composition and to the use of chemoembolization composition in the method for treating solid tumour cancers.
    Type: Application
    Filed: November 29, 2011
    Publication date: December 5, 2013
    Applicant: CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS
    Inventors: Alban Denys, Pierre Bize, Olivier Jordan, Eric Doelker, Nathalie Boulens